Strategic Signals Weekly
Licensing deals, strategic reviews, and financing events from regulatory filings. Part of the RxDataLab platform: clinical trials, SEC filings, and hedge fund positioning, linked by company.
Weekly Delivery
Get next week's Strategic Signals Weekly by email
One email per week. We follow up on coverage that's relevant to you.
or email [email protected]
Weekly Signal Volume
Licensing & Partnerships
New collaboration agreements, licensing deals, and partnership announcements.
| Filed | Company |
|---|---|
| Feb 4 | Entera Bio Ltd. (ENTX) ...Agreement Amended and Restated Collaboration and License Agreement As previously reported, on March 16, 2025, Entera Bio Ltd., a company organized under the laws of the State of Israel (the " Company "), entered into a collaboration and license agreement (the "...
[SEC] |
Financing Events
Capital raises, ATM programs, debt offerings, and other financing activities.
| Filed | Company |
|---|---|
| Feb 6 | RenovoRx, Inc. (RNXT) public offering
[SEC] |
| Feb 6 | Eikon Therapeutics (EIKN) public offering
[SEC] |
| Feb 6 | Cingulate Inc. (CING) $6.5M
private placement
[SEC] |
| Feb 5 | LB PHARMACEUTICALS INC (LBRX) $100.0M
private placement
[SEC] |
| Feb 5 | MBX Biosciences (MBX) $87.1M
atm
[SEC] |
| 6 more on the RxDataLab platform | |
About This Data
These events are extracted from SEC 8-K filings using keyword detection across the full filing text. Summaries are generated automatically from the filing content to describe what happened in plain language. We track five categories:
- FDA Actions (CRL): Companies that received a Complete Response Letter from the FDA, the agency's formal notice that a drug application cannot be approved as submitted.
- PDUFA Dates: Upcoming FDA decision deadlines disclosed via 8-K. A PDUFA date is the statutory deadline by which the FDA must complete its review of a new drug application.
- Strategic Reviews: Companies disclosing that they are exploring "strategic alternatives," potential sales, or board-level reviews of company direction.
- Licensing Deals: Material definitive agreements involving licensing, collaboration, or partnership arrangements. Requires multiple keyword matches to reduce noise.
- Financing Events: Capital raises, ATM offerings, registered direct transactions, and debt issuances. Filing proceeds are extracted where disclosed.
On the RxDataLab platform, each event is cross-referenced with the company's clinical trial pipeline, insider trading activity, and financials.
Data from RxDataLab and SEC EDGAR.